Santhera Pharmaceuticals announces the promotion of Geert Jan van Daal, MD, PhD, to Chief Commercial Officer and of Marc Schrader to Chief Technology Officer . Both will join the six-member Executive Committee effective January 1, 2024.
Who to call at Santhera Pharmaceuticals, and when
A new leader at Santhera Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Santhera Pharmaceuticals raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Santhera Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Santhera Pharmaceuticals. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Santhera Pharmaceuticals
Location
24 Hohenrainstrasse
Pratteln, Basel-Landschaft, Switzerland
About
Santhera Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of innovative medicines for the treatment of rare neuromuscular and pulmonary diseases.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Santhera Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.